Rosuvastatin therapy for people with HIV not associated with decreased biomarkers of inflammation and immune activation
1. Among virologically suppressed persons with HIV at moderate risk of cardiovascular disease, daily administration of rosuvastatin did not lead ...







![Endostatin directly binds androgen receptors to treat prostate cancer [PreClinical]](https://www.2minutemedicine.com/wp-content/uploads/2015/01/Endostatin-350x250.jpeg)
